Biomedical Research Institute of Malaga (IBIMA), Faculty of Science, University of Malaga, 29010 Málaga, Spain.
Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, University of Malaga (IBIMA), 29010 Málaga, Spain.
Genes (Basel). 2019 Sep 12;10(9):706. doi: 10.3390/genes10090706.
Obesity is associated with several comorbid disorders, ranging from cardiovascular diseases to insulin resistance. In this context, visceral adipose tissue (VAT) seems to have a close connection with insulin resistance. In our study, we hypothesized that the expression profile of key adipogenic genes, such as proliferator-activated receptor γ type 2 (PPAR-γ2), CCAAT/enhancer-binding protein type α (C/EBP-α), and forkhead box protein class O type 1 (FOXO1) in VAT should shed light on their association with obesity-related insulin resistance.
To test this idea, we studied the expression profile of C/EBP-α, FOXO1 and PPAR-γ2 in VAT from non-obese individuals, and low insulin (LIR-MO) and high insulin morbidly obese (HIR-MO) subjects, through a combination of RT-qPCR, co-immunoprecipitation, ELISA, Western blot analysis and EMSA assays.
Our results show that C/EBP-α and PPAR-γ2 were down-expressed in HIR-MO individuals, while FOXO1 was overexpressed. In addition, the PPAR-γ2-RXR-α heterodimer showed weak activity and bound weakly to the putative IGFBP-2-PPRE promoter sequence in VAT from HIR-MO subjects when compared with LIR-MO individuals.
These results show that PPAR-γ2, C/EBP-α, FOXO1 and IGFBP-2 have a close relationship with insulin resistance in VAT of morbidly obese individuals.
肥胖与多种合并症相关,范围从心血管疾病到胰岛素抵抗。在这种情况下,内脏脂肪组织(VAT)似乎与胰岛素抵抗密切相关。在我们的研究中,我们假设 VAT 中关键脂肪生成基因(如过氧化物酶体增殖物激活受体γ 型 2(PPAR-γ2)、CCAAT/增强子结合蛋白α(C/EBP-α)和叉头框蛋白 O 型 1(FOXO1)的表达谱)与肥胖相关的胰岛素抵抗有关。
为了验证这一想法,我们通过 RT-qPCR、共免疫沉淀、ELISA、Western blot 分析和 EMSA 检测,研究了非肥胖个体和低胰岛素(LIR-MO)和高胰岛素病态肥胖(HIR-MO)个体中 VAT 中 C/EBP-α、FOXO1 和 PPAR-γ2 的表达谱。
我们的结果表明,HIR-MO 个体中 C/EBP-α 和 PPAR-γ2 的表达下调,而 FOXO1 则过表达。此外,与 LIR-MO 个体相比,PPAR-γ2-RXR-α 异二聚体在 HIR-MO 个体的 VAT 中显示出较弱的活性,并且与假定的 IGFBP-2-PPRE 启动子序列的结合较弱。
这些结果表明,PPAR-γ2、C/EBP-α、FOXO1 和 IGFBP-2 与病态肥胖个体 VAT 中的胰岛素抵抗密切相关。